To compare the effects of lignocaine given as nebulization with intravenous lignocaine for decreasing of stress response to laryngoscopy and intubation in patients posted for elective general anaesthesia.
Phase 4
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2024/06/069435
- Lead Sponsor
- Hublikar Hemanth
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All ASA 1 and 2 patients between 18-65 years posted for elective surgeries under general anesthesia.
Exclusion Criteria
1) ASA grade 3 and 4.
2) Diabetic and Hypertensive patients.
3) known history of drug allergy.
4) Pregnant and lactating women.
5) Chronic respiratory and cardiovascular disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study and compare the effects of intravenous lignocaine IV 2% (2mg/kg) with nebulization of 2% lignocaine (2 mg/kg) on hemodynamic response to laryngoscopy and endotracheal intubation.Timepoint: From shifting on OT table till 15 minutes post endotracheal intubation
- Secondary Outcome Measures
Name Time Method To evaluate any side effects with use of this drug in both routesTimepoint: Baseline